Global Kidney Stone Market, By Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy), Diagnosis (Ultrasound, Intravenous Pyelography, CT Scan, X-Ray, Others) - Industry Trends and Forecast to 2030.
Kidney Stone Market Analysis and Size
Kidney stones are classified as deposits of salt and minerals that occur within the kidneys. Kidney stones are composed of calcium-oxalate and can also be made up, among others, of various other compounds such as cysteine, uric acid, and struvite. Kidney stones can affect individuals of all age groups; however, they are usually found in individuals between the ages of 20 to 40. Their involvement is called urolithiasis in the urinary tract, which is known as ureterolithiasis in the ureter.
Surging volume of patients suffering from urolithiasis, rising prevalence of geriatric population across the globe, increasing adoption of minimally invasive procedures for treatment of kidney stones, rising fast food consumption in developing regions, rising therapeutic demand and rapidly evolving healthcare sector are some of the major as well as vital factors which will likely to augment the growth of the kidney stone market in the projected timeframe of 2023-2030.
Data Bridge Market Research analyses that the kidney stone market was valued at USD 2,790.61 million in 2022 and is further estimated to reach USD 4,029.70 billion by 2030, and is expected to grow at a CAGR of 4.70% during the forecast period of 2023 to 2030. segment will hold the largest share in the growth of the market due to the good anatomical detail of the kidney in a short timeframe, with no exposure to radiation. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Kidney Stone Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2016 - 2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy), Diagnosis (Ultrasound, Intravenous Pyelography, CT Scan, X-Ray, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Boston Scientific Corporation or its affiliates (U.S.), Convergent Laser Technologies (U.S.), DirexGroup. (Germany), Siemens Healthcare GmbH, (Germany), BD (U.S.); Cook (U.S.), Dornier MedTech (Germany), Richard Wolf GmbH. (Germany), Olympus (Japan), KARL STORZ SE & Co. KG (Germany), Stryker (U.S.); Coloplast Ltd. (U.S.), Allengers (Ireland), Lumenis Ltd. (U.K.), EMS Urology (Switzerland), Medispec (India), EDAP TMS (France), Sonomotion (U.S.), CRESENTLASER, (U.S.), and Inceler Medikal Co. Ltd.(Turkey)
|
|
Market Opportunities
|
|
Market Definition
The global kidney stone market is the market for medical devices, drugs and treatments used to diagnose, prevent and treat kidney stones. Kidney stones, also known as kidney stones, are hard deposits that form in the kidneys when certain substances in the urine crystallize. The market includes various products and services for treating kidney stone-related diseases, including diagnostic tools, drugs, minimally invasive surgical procedures, shock wave lithotripsy, and dietary interventions.
Kidney Stone Market Dynamics
Drivers
- Rising Prevalence of Kidney Stones
The increasing prevalence of kidney stones worldwide is one of the major drivers of the kidney stones market. Factors such as unhealthy eating habits, sedentary lifestyle, and insufficient fluid intake increase the prevalence of kidney stones, creating demand for effective treatment options and fuelling market growth.
- Technological Advancements in Kidney Stone Treatment
The continuous technological advances in diagnostic tools and treatment options for kidney stones have significantly improved patient outcomes and reduced the invasiveness of procedures. The development of minimally invasive techniques such as laser lithotripsy and ureteroscopy has increased the use of kidney stone treatment and stimulated market growth.
- Growing Geriatric Population
The aging population is a significant driver of the kidney stone market. Elderly individuals are more susceptible to kidney stone formation due to age-related physiological changes and comorbidities. The expanding geriatric population base worldwide is expected to contribute to the increased demand for kidney stone management solutions, thus driving market growth.
Opportunities
- Emerging Markets
The kidney stone market offers significant growth opportunities in developing countries where the prevalence of kidney stones is increasing. Countries such as China, India, Brazil and others provide many patients, increase healthcare spending and increasingly focus on improving healthcare infrastructure, providing opportunities for market expansion.
- Rise in Product Innovations
The continuous innovation of medical devices and drugs used to treat kidney stones provides opportunities for market players. The development of advanced imaging techniques, new drugs and minimally invasive surgical instruments can improve treatment efficiency and patient comfort, thus stimulating market growth.
Restraints/Challenges
- High Treatment Costs
The cost of treating kidney stones, including diagnostic procedures, medications, and surgical procedures, can be a significant barrier for patients, especially in developing countries or those without adequate health insurance. High treatment costs limit market growth and access to quality care for some patients.
- Recurrence and Chronicity of Kidney Stones
Kidney stones tend to recur in individuals who have previously experienced them, leading to chronic kidney stone disease. Managing recurrent kidney stones can be challenging, requiring long-term treatment plans, lifestyle modifications, and regular monitoring. Developing effective strategies to prevent recurrent kidney stone formation and providing comprehensive management for chronic kidney stone patients pose challenges in the market.
This Kidney Stone Market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on theKidney Stone Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
-
In September 2021, Boston Scientific Corporation acquired Lumenis Ltd. for an upfront cash payment of USD 1.07 billion. It acquired Lumenis Ltd.’s global surgical business, which is into the development of energy-based medical solutions. This acquisition will allow Boston Scientific to use different medical solutions offered by Lumenis Ltd., including MOSES technology, which will help them expand their business
-
In September 2019, Dornier MedTech (Dornier), a urology firm and expert in kidney stone therapy, introduced the innovative OptiVision technology for the Dornier Delta III. It is the first imaging system that uses post-processing made exclusively to enhance stone therapy results. Urologists can visualize stones more clearly with OptiVision during extracorporeal shock wave lithotripsy (ESWL) procedures
Global Kidney Stone Market Scope
The kidney stone market is segmented based on type, treatment type, and diagnosis. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.
Type
- Calcium oxalate stones
- Uric acid
- Struvite kidney stones
- Cystine stones
- Calcium phosphate stones
Treatment Type
- Medications
- Extracorporeal shock wave lithotripsy
- Ureteroscopy
- Percutaneous nephrolithotomy
Diagnosis
- Ultrasound
- Intravenous pyelography
- Ct scan
- X-ray
- Others
Kidney Stone Market Regional Analysis/Insights
Kidney stone market is analysed and market size insights and trends are provided by country, type, treatment type, and diagnosis, as referenced above.
The countries covered in the kidney stone market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the kidney stone market due to the maximum occurrence and reoccurrence of kidney stones in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the rising therapeutic demand and rapidly evolving healthcare sector in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Kidney Stone Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the kidney stone market. The data is available for historic period 2015-2020.
Competitive Landscape and Kidney Stone Market Share Analysis
The kidney stone market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the kidney stone market are:
- Boston Scientific Corporation or its affiliates (U.S.)
- Convergent Laser Technologies (U.S.)
- DirexGroup. (Germany)
- Siemens Healthcare GmbH (Germany)
- BD (U.S.)
- Cook (U.S.)
- Dornier MedTech, (Germany)
- Richard Wolf GmbH. (Germany)
- Olympus (Japan)
- KARL STORZ SE & Co. KG (Germany)
- Stryker (U.S.)
- Coloplast Ltd. (US.)
- Allengers (Ireland)
- Lumenis Ltd. (U.K.)
- EMS Urology (Switzerland)
- Medispec (India)
- EDAP TMS (France)
- Sonomotion (U.S.)
- CRESENTLASER (U.S.)
- Inceler Medikal Co. Ltd.(Turkey)
SKU-